Guided meditation during radiation therapy for brain tumors

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional treatment assesses the effect of guided meditation on anxiety levels in patients undergoing radiation therapy for brain tumors. Participants will listen to a 5-minute audio-recorded mindfulness practice during each radiation session. The study compares the anxiety levels of those receiving the mindfulness intervention to those receiving standard care without any intervention. The goal is to determine if this mindfulness approach can effectively reduce acute anxiety during treatment.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Participant aged ≥ 18 years.
* Radiologically confirmed tumor of the brain. Note: Participants may have tumor resected after diagnosis.
* Eligible to undergo radiation treatment for brain tumor for 25-33 treatments.
* Willing to participate in either the guided meditation or standard of care control arm, regardless of treatment assignment.
* Karnofsky performance score ≥ 60 or ECOG performance score ≤ 2.
* MoCA mini score ≥ 11
* Able to provide informed consent and willing to sign an approved consent form that conforms to federal and institutional guidelines.

Exclusion Criteria:

* Active suicidal ideation or active psychotic state in the opinion of the investigator.
* An unstable illness that, in the opinion of the investigator, would interfere with study treatment.
* Prior radiation therapy to the brain.
* Inability to understand and/or speak the English language.

Where it's running

• Huntsman Cancer Institute
  Salt Lake City, Utah, United States Recruiting

Study contacts

• Principal investigator: Lindsay Burt, MD — Huntsman Cancer Institute
• Study coordinator: Rachel Kingsford
• Email: rachel.kingsford@hci.utah.edu
• Phone: 801-585-0115

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• YN003 injection in glioma patients

  This phase 1 study tests whether YN003 injected IV is safe and tolerable for adults with recurrent or progressive glioma, and to explore how the drug behaves in the body and any early signs of activity.

  Recruiting at 2 sites Phase 1 Beijing Inno Medicine Co., Ltd. · Los Angeles, California and 4 other locations · NCT07929909

• Connectome-guided navigation for eloquent-area brain tumor surgery

  We’re testing whether using a patient’s brain network maps to guide tumor removal in eloquent areas helps preserve function better than standard tractography-guided surgery.

  Recruiting Cancer Institute and Hospital, Chinese Academy of Medical Sciences · Beijing · NCT07657403

• Group occupational therapy program to help adults with primary brain tumours manage daily activities

  This program will try a six-week occupational therapy group to see if it helps adults with primary brain tumours on active treatment improve daily functioning and quality of life.

  Recruiting Royal College of Surgeons, Ireland · Dublin, Beaumont · NCT07426848

• Gadolinium-weighted MRI to better find brain metastases

  This will test a new MRI technique after gadolinium contrast to see if it finds more or smaller brain metastases in adults having a routine contrast brain MRI.

  Recruiting Region Stockholm · Stockholm, Solna · NCT07272616

• Fluorescence-guided suction monitoring to detect tumor tissue during brain surgery

  This trial will test a device that detects 5-ALA fluorescence in surgical suction to help surgeons find tumor tissue during adult glioma surgery.

  Recruiting University of Illinois Chicago · Chicago, Illinois · NCT07111182

• Home-based self-management and cognitive training for brain tumor survivors

  This trial will try a home-based cognitive coaching program to see if it improves thinking and quality of life for adults who survived non-glioblastoma brain tumors, with optional caregiver participation.

  Recruiting Dartmouth-Hitchcock Medical Center · Lebanon, New Hampshire · NCT06930846

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.